降圧剤の世界市場:販売動向2018

【英語タイトル】Global Antihypertensive Sales Market Report 2018

QYResearchが出版した調査資料(QYR80700941)・商品コード:QYR80700941
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:106
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、降圧剤の世界市場について調査・分析し、降圧剤のメーカー別販売量、市場シェア分析、種類別販売分析(利尿薬、アンギオテンシン受容体遮断薬(ARB)、アンギオテンシン変換酵素(ACE)阻害剤、β遮断薬、α遮断薬、その他)、用途別販売分析(病院、クリニック、在宅医療
    )、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、降圧剤産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・降圧剤市場概要
・降圧剤のメーカー別販売量・メーカー別シェア
・降圧剤の世界市場:種類別販売量(利尿薬、アンギオテンシン受容体遮断薬(ARB)、アンギオテンシン変換酵素(ACE)阻害剤、β遮断薬、α遮断薬、その他)
・降圧剤の世界市場:用途別販売量(病院、クリニック、在宅医療
    )
・降圧剤の世界市場:地域別販売量・市場シェア
・降圧剤の米国市場規模
・降圧剤の中国市場規模
・降圧剤の欧州市場規模
・降圧剤の日本市場規模
・降圧剤の東南アジア市場規模
・降圧剤のインド市場規模
・降圧剤のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・降圧剤のコスト分析・価格動向
・降圧剤の産業チェーン(サプライチェーン分析)
・降圧剤のマーケティング戦略・販売チャネル、流通業者
・降圧剤市場への影響要因分析
・降圧剤の世界市場予測
・降圧剤の米国市場予測
・降圧剤の中国市場予測
・降圧剤の欧州市場予測
・降圧剤の日本市場予測
・降圧剤の東南アジア市場予測
・降圧剤のインド市場予測
・降圧剤の種類別世界市場予測(利尿薬、アンギオテンシン受容体遮断薬(ARB)、アンギオテンシン変換酵素(ACE)阻害剤、β遮断薬、α遮断薬、その他)
・降圧剤の用途別世界市場予測(病院、クリニック、在宅医療
    )
...
【レポートの概要】

This report studies the global Antihypertensive market status and forecast, categorizes the global Antihypertensive market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
Antihypertensives are the drugs that are used to treat high blood pressure. This type of drug alleviate the complications of stroke and myocardial infarction.

The global Antihypertensive market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Pfizer
Novartis
Sanofi
Merck
Boehringer Ingelheim
Lupin
Johnson & Johnson
Astra Zeneca
Daiichi Sankyo
Ranbaxy

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diuretics 
Angiotensin receptor blockers (ARBs) 
Angiotensin converting enzyme (ACE) inhibitors 
Beta blockers
Alpha blockers
Calcium channel blockers 
Renin inhibitors
Vasodilators 
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hosptial
Clinic
Home

The study objectives of this report are:
To analyze and study the global Antihypertensive sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Antihypertensive players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antihypertensive are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antihypertensive Manufacturers
Antihypertensive Distributors/Traders/Wholesalers
Antihypertensive Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antihypertensive market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Antihypertensive Sales Market Report 2018
1 Antihypertensive Market Overview
1.1 Product Overview and Scope of Antihypertensive
1.2 Classification of Antihypertensive by Product Category
1.2.1 Global Antihypertensive Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Antihypertensive Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Diuretics 
1.2.4 Angiotensin receptor blockers (ARBs) 
1.2.5 Angiotensin converting enzyme (ACE) inhibitors 
1.2.6 Beta blockers
1.2.7 Alpha blockers
1.2.8 Calcium channel blockers 
1.2.9 Renin inhibitors
1.2.10 Vasodilators 
1.3 Global Antihypertensive Market by Application/End Users
1.3.1 Global Antihypertensive Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hosptial
1.3.2 Clinic
1.3.3 Home
1.4 Global Antihypertensive Market by Region
1.4.1 Global Antihypertensive Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Antihypertensive Status and Prospect (2013-2025)
1.4.3 Europe Antihypertensive Status and Prospect (2013-2025)
1.4.4 China Antihypertensive Status and Prospect (2013-2025)
1.4.5 Japan Antihypertensive Status and Prospect (2013-2025)
1.4.6 Southeast Asia Antihypertensive Status and Prospect (2013-2025)
1.4.7 India Antihypertensive Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Antihypertensive (2013-2025)
1.5.1 Global Antihypertensive Sales and Growth Rate (2013-2025)
1.5.2 Global Antihypertensive Revenue and Growth Rate (2013-2025)

2 Global Antihypertensive Competition by Players/Suppliers, Type and Application
2.1 Global Antihypertensive Market Competition by Players/Suppliers
2.1.1 Global Antihypertensive Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Antihypertensive Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Antihypertensive (Volume and Value) by Type
2.2.1 Global Antihypertensive Sales and Market Share by Type (2013-2018)
2.2.2 Global Antihypertensive Revenue and Market Share by Type (2013-2018)
2.3 Global Antihypertensive (Volume and Value) by Region
2.3.1 Global Antihypertensive Sales and Market Share by Region (2013-2018)
2.3.2 Global Antihypertensive Revenue and Market Share by Region (2013-2018)
2.4 Global Antihypertensive (Volume) by Application

3 United States Antihypertensive (Volume, Value and Sales Price)
3.1 United States Antihypertensive Sales and Value (2013-2018)
3.1.1 United States Antihypertensive Sales and Growth Rate (2013-2018)
3.1.2 United States Antihypertensive Revenue and Growth Rate (2013-2018)
3.1.3 United States Antihypertensive Sales Price Trend (2013-2018)
3.2 United States Antihypertensive Sales Volume and Market Share by Players (2013-2018)
3.3 United States Antihypertensive Sales Volume and Market Share by Type (2013-2018)
3.4 United States Antihypertensive Sales Volume and Market Share by Application (2013-2018)

4 Europe Antihypertensive (Volume, Value and Sales Price)
4.1 Europe Antihypertensive Sales and Value (2013-2018)
4.1.1 Europe Antihypertensive Sales and Growth Rate (2013-2018)
4.1.2 Europe Antihypertensive Revenue and Growth Rate (2013-2018)
4.1.3 Europe Antihypertensive Sales Price Trend (2013-2018)
4.2 Europe Antihypertensive Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Antihypertensive Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Antihypertensive Sales Volume and Market Share by Application (2013-2018)

5 China Antihypertensive (Volume, Value and Sales Price)
5.1 China Antihypertensive Sales and Value (2013-2018)
5.1.1 China Antihypertensive Sales and Growth Rate (2013-2018)
5.1.2 China Antihypertensive Revenue and Growth Rate (2013-2018)
5.1.3 China Antihypertensive Sales Price Trend (2013-2018)
5.2 China Antihypertensive Sales Volume and Market Share by Players (2013-2018)
5.3 China Antihypertensive Sales Volume and Market Share by Type (2013-2018)
5.4 China Antihypertensive Sales Volume and Market Share by Application (2013-2018)

6 Japan Antihypertensive (Volume, Value and Sales Price)
6.1 Japan Antihypertensive Sales and Value (2013-2018)
6.1.1 Japan Antihypertensive Sales and Growth Rate (2013-2018)
6.1.2 Japan Antihypertensive Revenue and Growth Rate (2013-2018)
6.1.3 Japan Antihypertensive Sales Price Trend (2013-2018)
6.2 Japan Antihypertensive Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Antihypertensive Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Antihypertensive Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Antihypertensive (Volume, Value and Sales Price)
7.1 Southeast Asia Antihypertensive Sales and Value (2013-2018)
7.1.1 Southeast Asia Antihypertensive Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Antihypertensive Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Antihypertensive Sales Price Trend (2013-2018)
7.2 Southeast Asia Antihypertensive Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Antihypertensive Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Antihypertensive Sales Volume and Market Share by Application (2013-2018)

8 India Antihypertensive (Volume, Value and Sales Price)
8.1 India Antihypertensive Sales and Value (2013-2018)
8.1.1 India Antihypertensive Sales and Growth Rate (2013-2018)
8.1.2 India Antihypertensive Revenue and Growth Rate (2013-2018)
8.1.3 India Antihypertensive Sales Price Trend (2013-2018)
8.2 India Antihypertensive Sales Volume and Market Share by Players (2013-2018)
8.3 India Antihypertensive Sales Volume and Market Share by Type (2013-2018)
8.4 India Antihypertensive Sales Volume and Market Share by Application (2013-2018)

9 Global Antihypertensive Players/Suppliers Profiles and Sales Data
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antihypertensive Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Novartis
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antihypertensive Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antihypertensive Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Merck
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antihypertensive Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Merck Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Boehringer Ingelheim
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antihypertensive Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Boehringer Ingelheim Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Lupin
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antihypertensive Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Lupin Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Johnson & Johnson
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antihypertensive Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Johnson & Johnson Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Astra Zeneca
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Antihypertensive Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Astra Zeneca Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Daiichi Sankyo
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Antihypertensive Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Daiichi Sankyo Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Ranbaxy
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Antihypertensive Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Ranbaxy Antihypertensive Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview

10 Antihypertensive Maufacturing Cost Analysis
10.1 Antihypertensive Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antihypertensive
10.3 Manufacturing Process Analysis of Antihypertensive

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antihypertensive Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antihypertensive Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Antihypertensive Market Forecast (2018-2025)
14.1 Global Antihypertensive Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Antihypertensive Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Antihypertensive Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Antihypertensive Price and Trend Forecast (2018-2025)
14.2 Global Antihypertensive Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Antihypertensive Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Antihypertensive Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Antihypertensive Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Antihypertensive Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Antihypertensive Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Antihypertensive Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Antihypertensive Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Antihypertensive Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Antihypertensive Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Antihypertensive Sales Forecast by Type (2018-2025)
14.3.2 Global Antihypertensive Revenue Forecast by Type (2018-2025)
14.3.3 Global Antihypertensive Price Forecast by Type (2018-2025)
14.4 Global Antihypertensive Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Antihypertensive
Figure Global Antihypertensive Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Antihypertensive Sales Volume Market Share by Type (Product Category) in 2017
Figure Diuretics  Product Picture
Figure Angiotensin receptor blockers (ARBs)  Product Picture
Figure Angiotensin converting enzyme (ACE) inhibitors  Product Picture
Figure Beta blockers Product Picture
Figure Alpha blockers Product Picture
Figure Calcium channel blockers  Product Picture
Figure Renin inhibitors Product Picture
Figure Vasodilators  Product Picture
Figure Global Antihypertensive Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Antihypertensive by Application in 2017
Figure Hosptial Examples
Table Key Downstream Customer in Hosptial
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Home Examples
Table Key Downstream Customer in Home
Figure Global Antihypertensive Market Size (Million USD) by Regions (2013-2025)
Figure United States Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Antihypertensive Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Antihypertensive Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Antihypertensive Sales Volume (K Units) (2013-2018)
Table Global Antihypertensive Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Antihypertensive Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Antihypertensive Sales Share by Players/Suppliers
Figure 2017 Antihypertensive Sales Share by Players/Suppliers
Figure Global Antihypertensive Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antihypertensive Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Antihypertensive Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Antihypertensive Revenue Share by Players
Table 2017 Global Antihypertensive Revenue Share by Players
Table Global Antihypertensive Sales (K Units) and Market Share by Type (2013-2018)
Table Global Antihypertensive Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Antihypertensive by Type (2013-2018)
Figure Global Antihypertensive Sales Growth Rate by Type (2013-2018)
Table Global Antihypertensive Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Antihypertensive Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Antihypertensive by Type (2013-2018)
Figure Global Antihypertensive Revenue Growth Rate by Type (2013-2018)
Table Global Antihypertensive Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Antihypertensive Sales Share by Region (2013-2018)
Figure Sales Market Share of Antihypertensive by Region (2013-2018)
Figure Global Antihypertensive Sales Growth Rate by Region in 2017
Table Global Antihypertensive Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antihypertensive Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antihypertensive by Region (2013-2018)
Figure Global Antihypertensive Revenue Growth Rate by Region in 2017
Table Global Antihypertensive Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Antihypertensive Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Antihypertensive by Region (2013-2018)
Figure Global Antihypertensive Revenue Market Share by Region in 2017
Table Global Antihypertensive Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Antihypertensive Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Antihypertensive by Application (2013-2018)
Figure Global Antihypertensive Sales Market Share by Application (2013-2018)
Figure United States Antihypertensive Sales (K Units) and Growth Rate (2013-2018)
Figure United States Antihypertensive Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Antihypertensive Sales Price (USD/Unit) Trend (2013-2018)
Table United States Antihypertensive Sales Volume (K Units) by Players (2013-2018)
Table United States Antihypertensive Sales Volume Market Share by Players (2013-2018)
Figure United States Antihypertensive Sales Volume Market Share by Players in 2017
Table United States Antihypertensive Sales Volume (K Units) by Type (2013-2018)
Table United States Antihypertensive Sales Volume Market Share by Type (2013-2018)
Figure United States Antihypertensive Sales Volume Market Share by Type in 2017
Table United States Antihypertensive Sales Volume (K Units) by Application (2013-2018)
Table United States Antihypertensive Sales Volume Market Share by Application (2013-2018)
Figure United States Antihypertensive Sales Volume Market Share by Application in 2017
Figure Europe Antihypertensive Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Antihypertensive Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Antihypertensive Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Antihypertensive Sales Volume (K Units) by Players (2013-2018)
Table Europe Antihypertensive Sales Volume Market Share by Players (2013-2018)
Figure Europe Antihypertensive Sales Volume Market Share by Players in 2017
Table Europe Antihypertensive Sales Volume (K Units) by Type (2013-2018)
Table Europe Antihypertensive Sales Volume Market Share by Type (2013-2018)
Figure Europe Antihypertensive Sales Volume Market Share by Type in 2017
Table Europe Antihypertensive Sales Volume (K Units) by Application (2013-2018)
Table Europe Antihypertensive Sales Volume Market Share by Application (2013-2018)
Figure Europe Antihypertensive Sales Volume Market Share by Application in 2017
Figure China Antihypertensive Sales (K Units) and Growth Rate (2013-2018)
Figure China Antihypertensive Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Antihypertensive Sales Price (USD/Unit) Trend (2013-2018)
Table China Antihypertensive Sales Volume (K Units) by Players (2013-2018)
Table China Antihypertensive Sales Volume Market Share by Players (2013-2018)
Figure China Antihypertensive Sales Volume Market Share by Players in 2017
Table China Antihypertensive Sales Volume (K Units) by Type (2013-2018)
Table China Antihypertensive Sales Volume Market Share by Type (2013-2018)
Figure China Antihypertensive Sales Volume Market Share by Type in 2017
Table China Antihypertensive Sales Volume (K Units) by Application (2013-2018)
Table China Antihypertensive Sales Volume Market Share by Application (2013-2018)
Figure China Antihypertensive Sales Volume Market Share by Application in 2017
Figure Japan Antihypertensive Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Antihypertensive Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Antihypertensive Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Antihypertensive Sales Volume (K Units) by Players (2013-2018)
Table Japan Antihypertensive Sales Volume Market Share by Players (2013-2018)
Figure Japan Antihypertensive Sales Volume Market Share by Players in 2017
Table Japan Antihypertensive Sales Volume (K Units) by Type (2013-2018)
Table Japan Antihypertensive Sales Volume Market Share by Type (2013-2018)
Figure Japan Antihypertensive Sales Volume Market Share by Type in 2017
Table Japan Antihypertensive Sales Volume (K Units) by Application (2013-2018)
Table Japan Antihypertensive Sales Volume Market Share by Application (2013-2018)
Figure Japan Antihypertensive Sales Volume Market Share by Application in 2017
Figure Southeast Asia Antihypertensive Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Antihypertensive Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Antihypertensive Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Antihypertensive Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Antihypertensive Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Antihypertensive Sales Volume Market Share by Players in 2017
Table Southeast Asia Antihypertensive Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Antihypertensive Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Antihypertensive Sales Volume Market Share by Type in 2017
Table Southeast Asia Antihypertensive Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Antihypertensive Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Antihypertensive Sales Volume Market Share by Application in 2017
Figure India Antihypertensive Sales (K Units) and Growth Rate (2013-2018)
Figure India Antihypertensive Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Antihypertensive Sales Price (USD/Unit) Trend (2013-2018)
Table India Antihypertensive Sales Volume (K Units) by Players (2013-2018)
Table India Antihypertensive Sales Volume Market Share by Players (2013-2018)
Figure India Antihypertensive Sales Volume Market Share by Players in 2017
Table India Antihypertensive Sales Volume (K Units) by Type (2013-2018)
Table India Antihypertensive Sales Volume Market Share by Type (2013-2018)
Figure India Antihypertensive Sales Volume Market Share by Type in 2017
Table India Antihypertensive Sales Volume (K Units) by Application (2013-2018)
Table India Antihypertensive Sales Volume Market Share by Application (2013-2018)
Figure India Antihypertensive Sales Volume Market Share by Application in 2017
Table Pfizer Basic Information List
Table Pfizer Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Antihypertensive Sales Growth Rate (2013-2018)
Figure Pfizer Antihypertensive Sales Global Market Share (2013-2018)
Figure Pfizer Antihypertensive Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Antihypertensive Sales Growth Rate (2013-2018)
Figure Novartis Antihypertensive Sales Global Market Share (2013-2018)
Figure Novartis Antihypertensive Revenue Global Market Share (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Antihypertensive Sales Growth Rate (2013-2018)
Figure Sanofi Antihypertensive Sales Global Market Share (2013-2018
Figure Sanofi Antihypertensive Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Antihypertensive Sales Growth Rate (2013-2018)
Figure Merck Antihypertensive Sales Global Market Share (2013-2018)
Figure Merck Antihypertensive Revenue Global Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Antihypertensive Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Antihypertensive Sales Global Market Share (2013-2018)
Figure Boehringer Ingelheim Antihypertensive Revenue Global Market Share (2013-2018)
Table Lupin Basic Information List
Table Lupin Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lupin Antihypertensive Sales Growth Rate (2013-2018)
Figure Lupin Antihypertensive Sales Global Market Share (2013-2018
Figure Lupin Antihypertensive Revenue Global Market Share (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Antihypertensive Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Antihypertensive Sales Global Market Share (2013-2018)
Figure Johnson & Johnson Antihypertensive Revenue Global Market Share (2013-2018)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Astra Zeneca Antihypertensive Sales Growth Rate (2013-2018)
Figure Astra Zeneca Antihypertensive Sales Global Market Share (2013-2018
Figure Astra Zeneca Antihypertensive Revenue Global Market Share (2013-2018)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Antihypertensive Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Antihypertensive Sales Global Market Share (2013-2018)
Figure Daiichi Sankyo Antihypertensive Revenue Global Market Share (2013-2018)
Table Ranbaxy Basic Information List
Table Ranbaxy Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ranbaxy Antihypertensive Sales Growth Rate (2013-2018)
Figure Ranbaxy Antihypertensive Sales Global Market Share (2013-2018)
Figure Ranbaxy Antihypertensive Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihypertensive
Figure Manufacturing Process Analysis of Antihypertensive
Figure Antihypertensive Industrial Chain Analysis
Table Raw Materials Sources of Antihypertensive Major Players in 2017
Table Major Buyers of Antihypertensive
Table Distributors/Traders List
Figure Global Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Antihypertensive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Antihypertensive Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Antihypertensive Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Antihypertensive Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Antihypertensive Sales Volume Market Share Forecast by Regions in 2025
Table Global Antihypertensive Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Antihypertensive Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Antihypertensive Revenue Market Share Forecast by Regions in 2025
Figure United States Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Antihypertensive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Antihypertensive Revenue and Growth Rate Forecast (2018-2025)
Figure China Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Antihypertensive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Antihypertensive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Antihypertensive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Antihypertensive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Antihypertensive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Antihypertensive Sales (K Units) Forecast by Type (2018-2025)
Figure Global Antihypertensive Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Antihypertensive Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Antihypertensive Revenue Market Share Forecast by Type (2018-2025)
Table Global Antihypertensive Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Antihypertensive Sales (K Units) Forecast by Application (2018-2025)
Figure Global Antihypertensive Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

降圧剤、利尿薬、アンギオテンシン受容体遮断薬(ARB)、アンギオテンシン変換酵素(ACE)阻害剤、β遮断薬、α遮断薬、病院、クリニック、在宅医療    

★調査レポート[降圧剤の世界市場:販売動向2018] (コード:QYR80700941)販売に関する免責事項を必ずご確認ください。
★調査レポート[降圧剤の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆